Skip to main content

Advertisement

Log in

Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Liu X, Wang M, Wang Q, Zhang H (2023) Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis. Breast Cancer Res Treat 202:221–231. https://doi.org/10.1007/s10549-023-07063-2

    Article  CAS  PubMed  Google Scholar 

  2. Cui Q, Dai L, Li J, Xue J (2020) Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and meta-analysis. World J Surg Oncol 18:112. https://doi.org/10.1186/s12957-020-01890-z

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mori N, Mugikura S, Miyashita M et al (2019) Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer. Jpn J Radiol 37:145–153. https://doi.org/10.1007/s11604-018-0792-6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoko Mori.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mori, N. Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes. Breast Cancer Res Treat 203, 629–630 (2024). https://doi.org/10.1007/s10549-023-07166-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-023-07166-w

Navigation